Intraportal prostaglandin E1 ameliorates the toxicity of intraportal 2′-deoxy-5-fluorouridine in rats
- 31 August 1987
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 43 (2) , 128-132
- https://doi.org/10.1016/0022-4804(87)90154-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Sclerosing Cholangitis after Continuous Hepatic Artery Infusiori of FUDRAnnals of Surgery, 1985
- Long-term Hepatic Arterial Infusion ChemotherapyArchives of Surgery, 1984
- A Prospective Phase II Clinical Trial of Continuous FUDR Regional Chemotherapy for Colorectal Metastases to the LiverAnnals of Surgery, 1983
- Protection of thermochemotherapeutic-induced lethal acute hepatic necrosis in the rat by 16,16-dimethyl prostaglandin E2Journal of Surgical Research, 1983
- Regional hepatic chemotherapy using an implantable drug infusion pumpThe American Journal of Surgery, 1983
- Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump: A feasibility study in 50 patientsThe American Journal of Surgery, 1983
- Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastasesCancer, 1982
- Protective effects of 16,16-dimethyl PGE2 on the liver and kidneyProstaglandins, 1981
- Comparison of prostacyclin and prostaglandin E2 on gastric secretion, gastrin release, and mucosal blood flow in dogsDigestive Diseases and Sciences, 1980
- Cytoprotection by prostaglandins in ratsGastroenterology, 1979